In advanced NSCLC EGFR Mutation Status test

被引：0
|
作者：
Schuette, Wolfgang [1 ]
机构：
[1] Krankenhaus Martha Maria, Klin Innere Med 2, Halle, Germany
来源：
ONKOLOGIE | 2012年 / 35卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：393 / 393
页数：1
相关论文
共 50 条
  • [1] Evaluation of concurrent chemoradiotherapy for locally advanced NSCLC according to EGFR mutation status
    Ishihara, Mikiko
    Igawa, Satoshi
    Sasaki, Jiichiro
    Otani, Sakiko
    Fukui, Tomoya
    Ryuge, Shinichiro
    Katono, Ken
    Hiyoshi, Yasuhiro
    Kasajima, Masashi
    Mitsufuji, Hisashi
    Kubota, Masaru
    Yokoba, Masanori
    Katagiri, Masato
    Sekiguchi, Akane
    Soda, Itaru
    Ishiyama, Hiromichi
    Hayakawa, Kazushige
    Masuda, Noriyuki
    [J]. ONCOLOGY LETTERS, 2017, 14 (01) : 885 - 890
  • [2] Optimizing measurement of EGFR mutation status in NSCLC
    Nicolson, M.
    Clark, C.
    Bell, C.
    Osborne, A.
    Tracey, J.
    Petty, R. D.
    Kerr, K. M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [3] Radiomic CT features for evaluation of EGFR and KRAS mutation status in patients with advanced NSCLC
    De Jong, E. E. C.
    Van Elmpt, W.
    Hendriks, L. E. L.
    Leijenaar, R. T. H.
    Dingemans, A. M. C.
    Lambin, P.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S290 - S291
  • [4] Osimertinib in EGFR Mutation-Positive Advanced NSCLC
    Roca, Elisa
    Amoroso, Vito
    Berruti, Alfredo
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (13): : 1261 - 1262
  • [5] EGFR Mutation Testing and First Line Treatment of Patients With Advanced NSCLC and Positive EGFR Mutation Status - Results From a German Registry
    Eberhardt, W.
    Thomas, M.
    von der Schulenburg, J. M. Graf
    Dietel, M.
    Schirmacher, P.
    Gutendorf, B.
    Zirrgiebel, U.
    Schuette, W.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S636 - S636
  • [6] ctDNA Determination of EGFR Mutation Status in European and Japanese Patients with Advanced NSCLC: The ASSESS Study
    Reck, Martin
    Hagiwara, Koichi
    Han, Baohui
    Tjulandin, Sergei
    Grohe, Christian
    Yokoi, Takashi
    Morabito, Alessandro
    Novello, Silvia
    Arriola, Edurne
    Molinier, Olivier
    McCormack, Rose
    Ratcliffe, Marianne
    Normanno, Nicola
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (10) : 1682 - 1689
  • [7] Diagnosis and Monitoring of EGFR Mutation Status with cfDNA in Advanced NSCLC: A Prospective Single Institution Study in Asia
    Chou, T.
    Ho, H.
    Chiu, C.
    Tsai, C.
    Das, P. M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2253 - S2253
  • [8] Deep analysis to inconsistent results of EGFR mutation status in tumor tissues and plasma DNA in advanced NSCLC.
    Wang, Jie
    Wan, Rui
    Bai, Hua
    Wang, Zhijie
    Zhao, Jun
    Zhuo, Minglei
    An, Tongtong
    Duan, Jianchun
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [9] Therapeutic effect of gefitinib on patients with advanced EGFR-mutation NSCLC
    Xu, Ailing
    Yan, Haixia
    Bu, Tongliang
    [J]. PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 34 (01) : 481 - 486
  • [10] EGFR mutation in NSCLC in Pakistan
    Ahmed, Z. A.
    Moatter, T.
    Pervez, S.
    Khan, W.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
12345